ReviewHeliyon2025
Impact of HER2-targeting antibody drug conjugates in treatment strategies for patients with breast cancer.
Hanghang Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewHeliyon2025
Hanghang Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.